Transepithelial Versus Epithelium-off Photorefractive Keratectomy in High Compound Myopic Astigmatism

Evidence database / Studies / peyman-2024-contralateral-transprk-prk

60enrolled patients*

60enrolled eyes*

2structured arms

180maximum standardized days follow-up

* Descriptive sum of reported arm counts. “≥” indicates that one or more arm counts were not reported; missing values are not treated as zero.

Study arm

Transepithelial PRK

TransPRK

Inclusion
Myopia with spherical equivalent at least -2.50 D and 3.00 D cylindrical refractive error.

Exclusion
Not structured

Outcome	Follow-up	Follow-up sample	Result	Reported fraction	Provenance
Mean residual cylinder refractive	6 months	30 eyes	0.51 D	Not reported	VERIFIED Source
Residual cylinder within 0.50 D predictability	6 months	30 eyes	76.0%	23 / 30 eyes	VERIFIED Source

No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.

Study arm

PRK

Inclusion
Myopia with spherical equivalent at least -2.50 D and 3.00 D cylindrical refractive error.

Exclusion
Not structured

Outcome	Follow-up	Follow-up sample	Result	Reported fraction	Provenance
Mean residual cylinder refractive	6 months	30 eyes	0.67 D	Not reported	VERIFIED Source
Residual cylinder within 0.50 D predictability	6 months	30 eyes	50.0%	15 / 30 eyes	VERIFIED Source

No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.